Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.

Nakayama K, Sakurai T, Katsu H.

Brain Res Bull. 2004 Apr 30;63(3):237-41.

PMID:
15145142
2.

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.

Millan MJ, Gobert A, Rivet JM, Adhumeau-Auclair A, Cussac D, Newman-Tancredi A, Dekeyne A, Nicolas JP, Lejeune F.

Eur J Neurosci. 2000 Mar;12(3):1079-95.

PMID:
10762339
3.

Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.

Ceglia I, Acconcia S, Fracasso C, Colovic M, Caccia S, Invernizzi RW.

Br J Pharmacol. 2004 Jun;142(3):469-78. Epub 2004 May 17.

4.

Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission.

Haddjeri N, Blier P, de Montigny C.

J Affect Disord. 1998 Dec;51(3):255-66.

PMID:
10333981
5.

Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex.

Sakaue M, Somboonthum P, Nishihara B, Koyama Y, Hashimoto H, Baba A, Matsuda T.

Br J Pharmacol. 2000 Mar;129(5):1028-34.

6.

Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex.

Sato M, Ago Y, Koda K, Nakamura S, Kawasaki T, Baba A, Matsuda T.

Eur J Pharmacol. 2007 Mar 22;559(2-3):155-60. Epub 2006 Dec 29.

PMID:
17258195
7.

Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.

Devoto P, Flore G, Pira L, Longu G, Gessa GL.

Eur J Pharmacol. 2004 Mar 8;487(1-3):105-11.

PMID:
15033381
8.

F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.

Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.

Eur J Pharmacol. 2009 Oct 12;620(1-3):27-35. doi: 10.1016/j.ejphar.2009.08.019. Epub 2009 Aug 18.

PMID:
19695244
9.

In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.

Iskra-Jopa J, Gołembiowska K, Dziubina A, Cybulski M, Duszyńska B, Chilmonczyk Z.

J Pharm Pharmacol. 2005 Feb;57(2):205-11.

PMID:
15720784
10.
11.

Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.

Li Z, Prus AJ, Dai J, Meltzer HY.

J Pharmacol Exp Ther. 2009 Sep;330(3):948-55. doi: 10.1124/jpet.109.155663. Epub 2009 Jun 2.

14.

Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.

Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P.

Br J Pharmacol. 2010 Aug;160(8):1929-40. doi: 10.1111/j.1476-5381.2010.00738.x.

16.

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.

Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.

Eur J Pharmacol. 2005 Mar 7;510(1-2):49-57.

PMID:
15740724
17.

Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex.

Nakayama K.

Naunyn Schmiedebergs Arch Pharmacol. 2002 Feb;365(2):102-5. Epub 2001 Dec 14.

PMID:
11819027
18.

Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.

Gardier AM, David DJ, Jego G, Przybylski C, Jacquot C, Durier S, Gruwez B, Douvier E, Beauverie P, Poisson N, Hen R, Bourin M.

J Neurochem. 2003 Jul;86(1):13-24.

19.

5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex.

Lacroix LP, Dawson LA, Hagan JJ, Heidbreder CA.

Synapse. 2004 Feb;51(2):158-64.

PMID:
14618683
20.

Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.

Petkova-Kirova P, Rakovska A, Zaekova G, Ballini C, Corte LD, Radomirov R, Vágvölgyi A.

Neurochem Int. 2008 Dec;53(6-8):355-61. doi: 10.1016/j.neuint.2008.08.010. Epub 2008 Sep 12.

PMID:
18835308

Supplemental Content

Support Center